journal article·2019-12-19

Generation of Size-Controlled Crystalline CeO2 Particles by Pulsed Laser Irradiation in Water

Yaakov Monsa, Gyora Gal, Ilana Bar

The Journal of Physical Chemistry C· Volume 123· Issue 50
Publisher page

Abstract

The defining characteristics of nanoparticles (NPs) include variation of properties as a function of size and shape, requiring their preparation with desirable dimensions and morphologies. Here, a unique approach based on pulsed laser irradiation in liquid (PLIL) was developed to reshape commercial CeO 2 NPs suspended in water in an attempt to respond to these challenges. Guided by the results of Mie theory and the predictions of the heating–melting–evaporation model, the fourth harmonic of an Nd:YAG laser (266 nm, 10 Hz, ∼5 ns) was selected and used for lateral irradiation of colloidal CeO 2 samples at particular laser fluences and number of laser pulses for producing size- and shape-specific crystalline NPs. Spectral and structural analyses of the NPs, prior to and following PLIL, revealed shape and crystal size alterations depending on the irradiation parameters, affecting melting, evaporation, and solidification of the particles. The change in size, shape, and agglomeration could be followed by the results of the analyses, where the first two could be also interpreted by the modeling results. This study demonstrates that controlled CeO 2 crystal particles, from nano- to submicrometer diameters, could be generated by PLIL, shedding new light on the dynamics of the process.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Laser-Ablation Synthesis of Nanoparticles · Laser-induced spectroscopy and plasma · Catalytic Processes in Materials Science

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Physics, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel

Department of Chemistry, Nuclear Research Center Negev, P.O. Box 9001, Beer-Sheva 8419001, Israel

Funding

Israel Science Foundation · PAZY Foundation

References (71)

Show source-provided references
1. 10.1039/C8RA08462A10.1039/C8RA08462A ↗
2. 10.1021/nn405387t10.1021/nn405387t ↗
3. 10.3762/bjnano.5.16510.3762/bjnano.5.165 ↗
4. 10.1038/nature2366110.1038/nature23661 ↗
5. 10.1126/science.121983110.1126/science.1219831 ↗
6. 10.1038/srep0984910.1038/srep09849 ↗
7. 10.1021/acs.jpcc.7b0018710.1021/acs.jpcc.7b00187 ↗
8. 10.1088/1361-6528/aa628210.1088/1361-6528/aa6282 ↗
9. 10.1007/s00340-015-6101-510.1007/s00340-015-6101-5 ↗
10. 10.1039/C8RA07067A10.1039/C8RA07067A ↗
11. Lau M. · 2016
12. 10.1002/adfm.20110229510.1002/adfm.201102295 ↗
13. 10.1002/lpor.20130001310.1002/lpor.201300013 ↗
14. 10.1002/anie.20100296310.1002/anie.201002963 ↗
15. 10.1021/jp983503o10.1021/jp983503o ↗
16. 10.1039/b709621f10.1039/b709621f ↗
17. 10.1002/lapl.20051008210.1002/lapl.200510082 ↗
18. 10.1021/am500443a10.1021/am500443a ↗
19. 10.1021/jp411958v10.1021/jp411958v ↗
20. 10.1039/C2RA22119E10.1039/C2RA22119E ↗
21. 10.1021/jp980009b10.1021/jp980009b ↗
22. 10.1021/jp112262u10.1021/jp112262u ↗
23. 10.1021/acs.jpcc.5b0208410.1021/acs.jpcc.5b02084 ↗
24. 10.1080/1040843100378823310.1080/10408431003788233 ↗
25. 10.1021/jp808300q10.1021/jp808300q ↗
26. 10.1016/j.jcis.2012.10.02710.1016/j.jcis.2012.10.027 ↗
27. 10.1002/cphc.20160117510.1002/cphc.201601175 ↗
28. 10.1016/j.apsusc.2017.10.23510.1016/j.apsusc.2017.10.235 ↗
29. 10.1038/am.2013.8810.1038/am.2013.88 ↗
30. 10.3390/antiox708009710.3390/antiox7080097 ↗
31. 10.1039/c2ee22310d10.1039/c2ee22310d ↗
32. 10.1039/C9TA04804A10.1039/C9TA04804A ↗
33. 10.1016/S1364-0321(02)00014-X10.1016/S1364-0321(02)00014-X ↗
34. 10.1023/A:102169610749810.1023/A:1021696107498 ↗
35. 10.1080/0161494960800646410.1080/01614949608006464 ↗
36. 10.1016/S0920-5861(98)00510-010.1016/S0920-5861(98)00510-0 ↗
37. 10.1038/nmat112910.1038/nmat1129 ↗
38. 10.1039/c0nr00875c10.1039/c0nr00875c ↗
39. 10.1039/c3sc50697e10.1039/c3sc50697e ↗
40. 10.1002/adhm.20120046410.1002/adhm.201200464 ↗
41. 10.1021/acs.molpharmaceut.7b0092010.1021/acs.molpharmaceut.7b00920 ↗
42. 10.1039/c0jm01072c10.1039/c0jm01072c ↗
43. 10.1002/adfm.20090236310.1002/adfm.200902363 ↗
44. 10.1007/s11182-016-0689-810.1007/s11182-016-0689-8 ↗
45. 10.1134/S106378501708012010.1134/S1063785017080120 ↗
46. 10.1007/s40843-017-9226-510.1007/s40843-017-9226-5 ↗
47. 10.1016/j.apsusc.2014.07.05310.1016/j.apsusc.2014.07.053 ↗
48. 10.1038/s41598-018-32528-610.1038/s41598-018-32528-6 ↗
49. 10.1002/andp.1908330030210.1002/andp.19083300302 ↗
50. Laven, P. MiePlot (A computer program for scattering of light from a sphere using Mie theory & the Debye series), 2011; http://www.philiplaven.com/mieplot.htm.
51. 10.1016/j.jphotochemrev.2012.01.00110.1016/j.jphotochemrev.2012.01.001 ↗
52. 10.1364/JOSA.48.00032410.1364/JOSA.48.000324 ↗
53. 10.4208/jams.081109.091809a10.4208/jams.081109.091809a ↗
54. 10.7567/JJAP.52.01AL0110.7567/JJAP.52.01AL01 ↗
55. 10.1063/1.482525610.1063/1.4825256 ↗
56. 10.7567/APEX.11.03500110.7567/APEX.11.035001 ↗
57. 10.1063/1.37201610.1063/1.372016 ↗
58. 10.2320/matertrans1989.41.110410.2320/matertrans1989.41.1104 ↗
59. 10.1021/cm050796710.1021/cm0507967 ↗
60. 10.1007/s11664-013-2617-910.1007/s11664-013-2617-9 ↗
61. 10.1063/1.166725110.1063/1.1667251 ↗
62. 10.1006/jcis.2001.804710.1006/jcis.2001.8047 ↗
63. 10.1016/j.ceramint.2004.09.00610.1016/j.ceramint.2004.09.006 ↗
64. Kreibig U. · 2013
65. Bohren C. F. · 1983
66. 10.1021/ac070208410.1021/ac0702084 ↗
67. 10.1016/j.scriptamat.2010.04.01910.1016/j.scriptamat.2010.04.019 ↗
68. 10.1103/PhysRevB.69.12541510.1103/PhysRevB.69.125415 ↗
69. 10.1021/jp903468m10.1021/jp903468m ↗
70. Abràmoff M. D. · Biophotonics Int. · 2004 · 11 · 36
71. 10.1007/s00339-010-5745-610.1007/s00339-010-5745-6 ↗